Platelet activation by fibrinolytic agents: a potential mechanism for resistance to thrombolysis and reocclusion after successful thrombolysis.
Leopold
J A
JA
Evans Department of Medicine, Boston University School of Medicine, Massachusetts, USA.
Loscalzo
J
J
D000818:Animals; D003251:Constriction, Pathologic; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects* / Q000502:physiology; D012008:Recurrence; D013300:Streptokinase / Q000494:pharmacology / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy / Q000503:physiopathology*; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator